Literature DB >> 15463386

Immunological tolerance: The key feature in human filariasis?

R M Maizels1, R A Lawrence.   

Abstract

Filariasis is a widespread tropical disease caused by a group of nematode parasites that can survive for many years in immunocompetent hosts. The paradox of filariasis has always been the inverse association between parasite density, in terms of circulating microfilariae in the blood, and severe pathology. In this review, Rick Maizels and Rachel Lawrence argue that microfilariae and adult parasites induce a form of immunological tolerance which prevents both parasite elimination and progression to disease. The breakdown of this unresponsiveness is seen as the critical step towards pathogenesis. However, not every exposed individual progresses through infection to disease. The authors discuss evidence for protective immunity acting on antigens from the mosquito-borne infective larva, and propose that this stage represents a vulnerable target outside the scope of tolerance and pathogenesis. Stage-specific larval antigens, to which asymptomatic hosts are known to respond, may therefore represent the most effective and safe choice for an anti filarial vaccine.

Entities:  

Year:  1991        PMID: 15463386     DOI: 10.1016/0169-4758(91)90093-4

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  32 in total

1.  An unlikely partnership: parasites, concomitant immunity and host defence.

Authors:  S P Brown; B T Grenfell
Journal:  Proc Biol Sci       Date:  2001-12-22       Impact factor: 5.349

2.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Fine specificity of the genetically controlled immune response to native and recombinant gp15/400 (polyprotein allergen) of Brugia malayi.

Authors:  J E Allen; R A Lawrence; R M Maizels
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

4.  Past exposure and the dynamics of lymphatic filariasis infection in young children.

Authors:  A Srividya; P K Das; S Subramanian; K D Ramaiah; B T Grenfell; E Michael; D A Bundy
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

5.  Population biology of human onchocerciasis.

Authors:  M G Basáñez; M Boussinesq
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

6.  Molecular characterization and evaluation of Onchocerca volvulus-secreted larval acidic protein 1 (SLAP1) as a putative vaccine candidate on endemic population of lymphatic filariasis.

Authors:  Natarajan Mahalakshmi; Ramanathan Aparnaa; Lawrance Ansel Vishal; Perumal Kaliraj
Journal:  Parasitol Res       Date:  2013-07-05       Impact factor: 2.289

7.  Lymphatic filariasis: diagnosis and pathogenesis. WHO expert committee on filariasis.

Authors: 
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

8.  Loss of Th1-associated function in peripheral T cells but not thymocytes in tolerance to major histocompatibility complex alloantigen.

Authors:  P J Wood; I A Cossens
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.

Authors:  S K Verma; I Bansal; S Vedi; J K Saxena; V M Katoch; S M Bhattacharya
Journal:  Parasitol Res       Date:  2007-12-07       Impact factor: 2.289

10.  Effect of activated antigen-specific B cells on ES-62-mediated modulation of effector function of heterologous antigen-specific T cells in vivo.

Authors:  Fraser A Marshall; Katherine A Watson; Paul Garside; Margaret M Harnett; William Harnett
Journal:  Immunology       Date:  2007-10-23       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.